Neovacs SA (ALNEV):企業財務及び戦略的SWOT分析

◆英語タイトル:Neovacs SA (ALNEV) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム


Neovacs SA (Neovacs) develops various vaccines. The company offers TNF- kinoid and IFNa- kinoid products used for the treatment of rheumatoid arthritis, Crohn’s disease, cancer; and systemic lupus erythematosus (SLE) or lupus, receptively. Neovacs’ pipeline portfolio also offers VEGF-Kinoid for the treatment of Age-Related Macular Degeneration (AMD) and solid tumors and IL4-Kinoid for the treatment of allergies. The company develops products using its proprietary kinoid technology that target cytokines for treatment of chronic autoimmune and inflammatory diseases. It conducts research and development activities on other high potential cytokine targets. Neovacs is headquartered in Paris, Ile-de-France, France.

Neovacs SA Key Recent Developments

Sep 30, 2016: Neovacs: Half-Year Results 2016 and Update on Operational Development
Sep 30, 2016: Half-Year Results 2016 and Update on Operational Development
Jul 19, 2016: Neovacs and Stellar Biotechnologies Announce changes of Administrative Board and Management Team
May 17, 2016: Neovacs to attend ChinaBio Event May 18 & 19, 2016
Mar 07, 2016: Neovacs Reports Full Year 2015 Financial Results

This comprehensive SWOT profile of Neovacs SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neovacs SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Neovacs SA – Key Information
Neovacs SA – Overview
Neovacs SA – Key Employees
Neovacs SA – Key Employee Biographies
Neovacs SA – Key Operational Heads
Neovacs SA – Major Products and Services
Neovacs SA – History
Neovacs SA – Company Statement
Neovacs SA – Locations And Subsidiaries
Neovacs SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Neovacs SA – Business Description
Neovacs SA – Corporate Strategy
Neovacs SA – SWOT Analysis
SWOT Analysis – Overview
Neovacs SA – Strengths
Neovacs SA – Weaknesses
Neovacs SA – Opportunities
Neovacs SA – Threats
Neovacs SA – Key Competitors

Section 3 – Company Financial Performance Charts

Neovacs SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Neovacs SA, Key Information
Neovacs SA, Key Ratios
Neovacs SA, Share Data
Neovacs SA, Major Products and Services
Neovacs SA, History
Neovacs SA, Key Employees
Neovacs SA, Key Employee Biographies
Neovacs SA, Key Operational Heads
Neovacs SA, Other Locations
Neovacs SA, Subsidiaries
Neovacs SA, Key Manufacturing facilities
Neovacs SA, Key Competitors
Neovacs SA, SWOT Analysis
Neovacs SA, Ratios based on current share price
Neovacs SA, Annual Ratios
Neovacs SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Neovacs SA, Performance Chart
Neovacs SA, Ratio Charts


★リサーチレポート[ Neovacs SA (ALNEV):企業財務及び戦略的SWOT分析(Neovacs SA (ALNEV) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。